Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)
Clinical trial NCT01243944 · COMPLETED
Trial details
- NCT number
- NCT01243944
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-27
- Primary completion
- 2014-01-15
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.